[
  {
    "ts": "2025-12-16T08:03:00+00:00",
    "headline": "‘Zombie’ biotech buyer Xoma to acquire Generation Bio",
    "summary": "The gene therapy developer has lost most of its value since going public in 2020 and saw a long road ahead for a delivery technology that had shown promise in preclinical tests.",
    "url": "https://www.biopharmadive.com/news/xoma-generation-acquisition-zombie-biotech/807974/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "9b5a00a1-a1e1-3f4e-ad27-de02f273a617",
      "content": {
        "id": "9b5a00a1-a1e1-3f4e-ad27-de02f273a617",
        "contentType": "STORY",
        "title": "‘Zombie’ biotech buyer Xoma to acquire Generation Bio",
        "description": "",
        "summary": "The gene therapy developer has lost most of its value since going public in 2020 and saw a long road ahead for a delivery technology that had shown promise in preclinical tests.",
        "pubDate": "2025-12-16T08:03:00Z",
        "displayTime": "2025-12-16T08:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/34d6c5fbf359c6d3a31700d37306dc4f",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dJRTLW0Pp2SXwhrqcdVoCw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/34d6c5fbf359c6d3a31700d37306dc4f.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eQE3YxBjs9PyQn0VImbWzg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/34d6c5fbf359c6d3a31700d37306dc4f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/xoma-generation-acquisition-zombie-biotech/807974/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zombie-biotech-buyer-xoma-acquire-080300783.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GBIO"
            },
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T14:55:00+00:00",
    "headline": "CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike",
    "summary": "CHMP backs EU approval of Moderna's next-generation mNexspike COVID-19 vaccine, with a final European Commission decision expected shortly.",
    "url": "https://finance.yahoo.com/news/chmp-backs-eu-approval-mrnas-145500012.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b305cce0-7a1f-3a7e-bf8e-9b7e8b209720",
      "content": {
        "id": "b305cce0-7a1f-3a7e-bf8e-9b7e8b209720",
        "contentType": "STORY",
        "title": "CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike",
        "description": "",
        "summary": "CHMP backs EU approval of Moderna's next-generation mNexspike COVID-19 vaccine, with a final European Commission decision expected shortly.",
        "pubDate": "2025-12-16T14:55:00Z",
        "displayTime": "2025-12-16T14:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e57c38ef2cab6e9081bde6f59c7a4095",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E9t3mk6J0lesVKcjZ2SgQA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e57c38ef2cab6e9081bde6f59c7a4095.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iEzDa9vreyHFcwlV4oyI1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e57c38ef2cab6e9081bde6f59c7a4095.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/chmp-backs-eu-approval-mrnas-145500012.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/chmp-backs-eu-approval-mrnas-145500012.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T14:06:56+00:00",
    "headline": "Moderna (MRNA) Is Up 5.9% After EMA Backs New mNEXSPIKE Vaccine - Has The Bull Case Changed?",
    "summary": "The European Medicines Agency’s Committee for Medicinal Products for Human Use previously issued a positive opinion recommending marketing authorization of Moderna’s new COVID-19 vaccine, mNEXSPIKE (mRNA-1283), for individuals aged 12 and older, following Phase 3 data showing higher relative efficacy versus Spikevax. This potential EU approval would broaden Moderna’s respiratory vaccine lineup and regional footprint, partly counterbalancing pressure from weakening COVID-19 vaccine...",
    "url": "https://finance.yahoo.com/news/moderna-mrna-5-9-ema-140656712.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "2e5195e7-5206-321f-b923-10c320764fcd",
      "content": {
        "id": "2e5195e7-5206-321f-b923-10c320764fcd",
        "contentType": "STORY",
        "title": "Moderna (MRNA) Is Up 5.9% After EMA Backs New mNEXSPIKE Vaccine - Has The Bull Case Changed?",
        "description": "",
        "summary": "The European Medicines Agency’s Committee for Medicinal Products for Human Use previously issued a positive opinion recommending marketing authorization of Moderna’s new COVID-19 vaccine, mNEXSPIKE (mRNA-1283), for individuals aged 12 and older, following Phase 3 data showing higher relative efficacy versus Spikevax. This potential EU approval would broaden Moderna’s respiratory vaccine lineup and regional footprint, partly counterbalancing pressure from weakening COVID-19 vaccine...",
        "pubDate": "2025-12-16T14:06:56Z",
        "displayTime": "2025-12-16T14:06:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lV6Oo0M_C3X63uXoBkpnwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KdbFtaQiMRVA6Enl712wNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-5-9-ema-140656712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-5-9-ema-140656712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]